Addressing a clear unmet medical need in the personalized adjuvant treatment of early-stage breast cancer.
Joined January 2021
- Tweets 1
- Following 38
- Followers 48
- Likes 0
Photos and videos
30 Sep 2021
Inbiomotion’s MAF Test® selects breast cancer patients benefitting from adjuvant clodronate, significantly improving their overall survival. inbiomotion.com/news/
7
14